Teladoc Health to Announce Fourth Quarter 2022 Financial Results

3 years ago

PURCHASE, NY, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,…

H1 is Named to the New York Digital Health 100 For Second Straight Year

3 years ago

Exclusive list recognizes most exciting and innovative health startups in the New York regionNEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE)…

ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits

3 years ago

Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a…

Novo Nordisk files annual report with the SEC

3 years ago

Bagsværd, Denmark, 1 February 2023 – Novo Nordisk A/S has filed its Annual Report 2022 on Form 20-F for the…

OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report

3 years ago

WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively…

Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

3 years ago

FDA Agrees to Extended Milestones for Long-Term Twirla® Safety Study New Publication Supports Eventual Pursuit of AG200-15 Extended Regimen Development…

Cue Biopharma to Present at Two February 2023 Scientific Conferences

3 years ago

BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of…

Recludix Pharma to Present at the Guggenheim Healthcare Talks Oncology Conference

3 years ago

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging…

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

3 years ago

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science…

Bolt Biotherapeutics to Present at February Investor Conferences

3 years ago

REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncology…